Key result
Homozygous RyR1 mutations associated with core myopathies abolish or greatly reduce sarcoplasmic reticulum Ca(2+) release, while heterotetrameric channels maintain partial function.
Homozygous RyR1 mutations linked to core myopathies abolish sarcoplasmic reticulum Ca2+ release, whereas heterozygous expression maintains partial Ca2+ release capacity.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in animal models; leaves open human validation of RyR1 channel effects in core myopathies.
Skeletal muscle excitation-contraction coupling involves activation of homotetrameric ryanodine receptor ion channels (RyR1s), resulting in the rapid release of Ca(2+) from the sarcoplasmic reticulum. Previous work has shown that Ca(2+) release is impaired by mutations in RyR1 linked to Central Core Disease and Multiple Minicore Disease. We studied the consequences of these mutations on RyR1 function, following their expression in human embryonic kidney 293 cells and incorporation in lipid bilayers. RyR1-G4898E, -G4898R, and -DeltaV4926/I4927 mutants in the C-terminal pore region of RyR1 and N-terminal RyR1-R110W/L486V mutant all showed negligible Ca(2+) permeation and loss of Ca(2+)-dependent channel activity but maintained reduced K(+) conductances. Co-expression of wild type and mutant RyR1s resulted in Ca(2+)-dependent channel activities that exhibited intermediate Ca(2+) selectivities compared with K(+), which suggested the presence of tetrameric RyR1 complexes composed of wild type and mutant subunits. The number of wild-type subunits to maintain a functional heterotetrameric channel differed among the four RyR1 mutants. The results indicate that homozygous RyR1 mutations associated with core myopathies abolish or greatly reduce sarcoplasmic reticulum Ca(2+) release during excitation-contraction coupling. They further suggest that in individuals, expressing wild type and mutant alleles, a substantial portion of RyR1 channels is able to release Ca(2+) from sarcoplasmic reticulum.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2008) studied Core myopathies (Central Core Disease and Multiple Minicore Disease). RyR1 mutations (RyR1-G4898E, -G4898R, -DeltaV4926/I4927, RyR1-R110W/L486V) vs. Wild type RyR1 was evaluated on Ca(2+) permeation and Ca(2+)-dependent channel activity. Homozygous RyR1 mutations associated with core myopathies abolish or greatly reduce sarcoplasmic reticulum Ca(2+) release, while heterotetrameric channels maintain partial function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: